Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 11.6B | 10.5B | 10.0B | 9.8B |
Cost of revenue | 2.1B | 2.4B | 1.7B | 1.7B |
Gross profit | 9.4B | 8.1B | 8.3B | 8.1B |
Operating expense | ||||
Research & development | 3.6B | 2.4B | 2.3B | 2.2B |
Selling general and admin | 4.3B | 4.1B | 3.9B | 3.6B |
Other operating expenses | — | — | — | — |
Operating income | 1.6B | 1.6B | 2.1B | 2.4B |
Non operating interest income | ||||
Income | 49.7M | 142.0M | 77.6M | 86.1M |
Expense | 332.9M | 354.6M | 343.7M | 320.4M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 1.4B | 1.9B | 2.2B |
Tax provision | 128.8M | 306.5M | 363.9M | 481.1M |
Net income | 1.2B | 1.1B | 1.5B | 1.7B |
Basic EPS | 1.0 | 0.9 | 1.2 | 1.4 |
Diluted EPS | 1.0 | 0.9 | 1.2 | 1.4 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.5B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | 3.4B | 3.2B | 3.2B | 3.5B |
Net income from continuing op. | 1.3B | 1.4B | 1.9B | 2.2B |
Minority interests | 0 | -3.1M | -775.9K | -775.9K |
Preferred stock dividends | 0 | 0 | 0 | 0 |